Medical and Pharmaceutical Cizzle Biotech rises 16% from U.S. launch of lung cancer blood test The CIZ1B test is meant to complement LDCT in detecting early-stage disease Rowan DunneJuly 23, 2026
Medical and Pharmaceutical Mercy BioAnalytics raises US$59M to commercialize ovarian cancer blood test The American Cancer Society was a significant funding contributor Rowan DunneSeptember 3, 2025